As Study of the Pharmacokinetics of Paliperidone Extended-release and Risperidone Immediate-release Formulations
Phase 1
Completed
- Conditions
- SchizophreniaSchizoaffective Disorder
- First Posted Date
- 2008-11-24
- Last Posted Date
- 2011-06-08
- Target Recruit Count
- 62
- Registration Number
- NCT00796185
A Dose-proportionality Study of Five Tablet Strengths of ER OROS Paliperidone
Phase 1
Completed
- Conditions
- Schizophrenia
- First Posted Date
- 2008-11-24
- Last Posted Date
- 2011-05-24
- Target Recruit Count
- 50
- Registration Number
- NCT00796835
A Study of the Effects of Paroxetine on the Pharmacokinetics of Paliperidone ER
Phase 1
Completed
- Conditions
- Schizophrenia
- First Posted Date
- 2008-11-14
- Last Posted Date
- 2011-05-19
- Target Recruit Count
- 60
- Registration Number
- NCT00791713
A Study of QT and QTc Intervals in Patients Administered Immediate Release Paliperidone
Phase 1
Completed
- Conditions
- SchizophreniaSchizoaffective Disorder
- First Posted Date
- 2008-11-14
- Last Posted Date
- 2011-06-08
- Target Recruit Count
- 141
- Registration Number
- NCT00791349
A Study of Extended Release Extended-release (ER) OROS Paliperidone Tolerability, as Compared to Immediate-release (IR)Risperidone, in Patients With Schizophrenia
Phase 1
Completed
- Conditions
- Schizophrenia
- First Posted Date
- 2008-11-14
- Last Posted Date
- 2011-06-08
- Target Recruit Count
- 113
- Registration Number
- NCT00791232
A Study of QT and QTc Intervals in Patients Administered Extended Release Paliperidone or Quetiapine
Phase 1
Completed
- Conditions
- SchizophreniaSchizoaffective Disorder
- First Posted Date
- 2008-11-14
- Last Posted Date
- 2011-05-18
- Target Recruit Count
- 110
- Registration Number
- NCT00791622
A Study of the Dose Proportionality of Extended Release Paliperidone
Phase 1
Completed
- Conditions
- Schizophrenia
- First Posted Date
- 2008-11-14
- Last Posted Date
- 2011-05-18
- Target Recruit Count
- 58
- Registration Number
- NCT00791167
A Pharmacokinetic Study of the Relative Bioavailability of Paliperidone ER Formulations With Different Release Profiles and a Comparison to Paliperidone IR
Phase 1
Completed
- Conditions
- Schizophrenia
- First Posted Date
- 2008-11-14
- Last Posted Date
- 2011-05-18
- Target Recruit Count
- 80
- Registration Number
- NCT00791193
A Study of the Pharmacokinetics of Paliperidone in Volunteers With Normal or Impaired Liver Function
Phase 1
Completed
- Conditions
- SchizophreniaHepatic Impairment
- First Posted Date
- 2008-11-14
- Last Posted Date
- 2011-06-08
- Target Recruit Count
- 20
- Registration Number
- NCT00791284
A Study of the Bioequivalence of 12 mg Paliperidone Extended Release Tablets Manufactured at Gurabo and Vacaville
Phase 1
Completed
- Conditions
- Schizophrenia
- First Posted Date
- 2008-11-14
- Last Posted Date
- 2011-05-18
- Target Recruit Count
- 72
- Registration Number
- NCT00790777
© Copyright 2025. All Rights Reserved by MedPath